Kong, B. Et Al. 2010. AZGP1 is a tumor suppressor in pancreatic cancer inducing mesenchymal-to-epithelial transdifferentiation by inhibiting TGF-beta-mediated ERK signaling. ONCOGENE , vol.29, no.37 , 5146-5158.

Kong, B., Michalski, C. W., Hong, X., Valkovskaya, N., Rieder, S., Abiatari, I., ... Streit, S.(2010). AZGP1 is a tumor suppressor in pancreatic cancer inducing mesenchymal-to-epithelial transdifferentiation by inhibiting TGF-beta-mediated ERK signaling. ONCOGENE , vol.29, no.37, 5146-5158.

Kong, B. Et Al. "AZGP1 is a tumor suppressor in pancreatic cancer inducing mesenchymal-to-epithelial transdifferentiation by inhibiting TGF-beta-mediated ERK signaling," ONCOGENE , vol.29, no.37, 5146-5158, 2010

Kong, B. Et Al. "AZGP1 is a tumor suppressor in pancreatic cancer inducing mesenchymal-to-epithelial transdifferentiation by inhibiting TGF-beta-mediated ERK signaling." ONCOGENE , vol.29, no.37, pp.5146-5158, 2010

Kong, B. Et Al. (2010) . "AZGP1 is a tumor suppressor in pancreatic cancer inducing mesenchymal-to-epithelial transdifferentiation by inhibiting TGF-beta-mediated ERK signaling." ONCOGENE , vol.29, no.37, pp.5146-5158.

@article{article, author={B. Kong Et Al. }, title={AZGP1 is a tumor suppressor in pancreatic cancer inducing mesenchymal-to-epithelial transdifferentiation by inhibiting TGF-beta-mediated ERK signaling}, journal={ONCOGENE}, year=2010, pages={5146-5158} }